Interviews

Allison Aguado, MD
Transarterial Oncologic Interventions in Children
April 09, 2021
IO Learning invited Allison S. Aguado, MD, to discuss her 2021 Society of Interventional Radiology (SIR) presentation on the efficacy of minimally invasive interventional radiology treatments in pediatric cancer patients.
Dr Lacey 3
Angio-CT: Why You Should Invest — Clinical, Operational, and Economic Perspectives From an Early Adopter
December 22, 2020
IO Learning spoke with Dr David Lacey, who was one of the first interventionists in the United States to utilize the Siemens Angio-CT, and was instrumental in the development of the current generation, Nexaris.
Dr Lencioni
CIO 2020 Best Posters: The EMERALD-1 Study
November 06, 2020
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at CIO 2020 and was designated as a “CIO Best Poster.”
Dr S. Ali Montazeri
CIO 2020 Best Posters: Radiation Segmentectomy as Primary Therapy for HCC
November 06, 2020
There is increasing evidence to support the concept of ablative-intent radioembolization, but the literature remains sparse for solitary HCC. We spoke with S. Ali Montazeri, MD, MPH, who presented his research on this topic at CIO 2020.
Dr Nishita Kothary
A Cost-Effectiveness Analysis of cTACE vs DEB-TACE
September 24, 2020
IO Learning invited Dr Nishita Kothary to discuss her 2020 SIR abstract, “Comparison of Drug-Eluting Beads versus Conventional Transarterial Chemoembolization: A Cost-Effectiveness Analysis.”
Dr Laage Gaupp
The Tanzania Interventional Radiology Initiative: An Update From the Road2IR Global Outreach Program
September 18, 2020
Dr Fabian Laage Gaupp, co-founder of the Tanzanian IR Initiative, discusses the current status of the program, as well as challenges faced during the COVID pandemic.
Dr Bela Kis
Promising Treatment Option for Unresectable Pleural Mesothelioma
July 13, 2020
IO Learning invited Bela Kis, MD, PhD, to discuss his 2020 SIR Abstract of the Year, “Transarterial Chemoperfusion Treatment of Unresectable Pleural Mesothelioma: Interim Results of a Phase 2 Prospective Study.”
RenovoCath Device
A Novel Dual-Balloon Catheter for the Treatment of Locally Advanced Pancreatic Cancer
June 09, 2020
Dr Ripal Gandhi discusses his 2020 SIR abstract, “Overcoming Limitations in the Treatment of Locally Advanced Pancreatic Cancer With Transarterial Microperfusion Utilizing a Novel Dual-Balloon Catheter."
Busch
Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer Treatment: An Interview With Joseph J. Busch, Jr., MD
April 18, 2020
Dr Busch spoke with IO Learning about integrating the recently FDA-approved TULSA treatment into his practice.
Dr Yolanda Bryce
Current Therapies and Future Options for Breast Cancer Treatment: An Interview With Yolanda Bryce, MD
March 25, 2020
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
Dr Philip Low
Tumor-Targeted Dyes for Fluorescence-Guided Cancer Treatment: An Interview With Philip Low, MD
March 09, 2020
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Back to Top